Margreet Lang

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus

Bernard M. Tijink, Jan Buter, Remco de Bree et al. · Clinical Cancer Research · 2006 · 316 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacology +17

Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer.

Ernst J. Postema, Pontus K.E. Börjesson, W C Buijs et al. · PubMed · 2003 · 42 citations

Medicine, Nuclear Medicine, Oncology +17

Telmisartan and Amlodipine Single‐Pill Combinations vs Amlodipine Monotherapy for Superior Blood Pressure Lowering and Improved Tolerability in Patients With Uncontrolled Hypertension: Results of the TEAMSTA‐5 Study

Steen Neldam, Margreet Lang, Russell Jones · Journal of Clinical Hypertension · 2011 · 41 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

A phase II study of temozolomide in hormone-refractory prostate cancer

J.P. van Brussel, Martijn B. Busstra, Margreet Lang et al. · Cancer Chemotherapy and Pharmacology · 2000 · 32 citations

Medicine, Oncology, Pharmacology +10

Long-Term Tolerability and Efficacy of Single-Pill Combinations of Telmisartan 40–80 mg Plus Amlodipine 5 or 10 mg in Patients Whose Blood Pressure Was Not Initially Controlled by Amlodipine 5–10 mg: Open-Label, Long-Term Follow-Ups of the TEAMSTA-5 and TEAMSTA-10 Studies

Steen Neldam, C. Edwards, Margreet Lang et al. · Current Therapeutic Research · 2012 · 10 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17